Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue for COVID-19
NCT05004805Phase 2Completed
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue in coronavirus disease 2019 (COVID-19). Started Aug 2021; status: completed.
02
Drugs
methylene blue
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05004805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05004805.